Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.060 GeneticVariation phenotype BEFREE Pain and Medical Outcomes Study Sleep questionnaire (MOS-Sleep) were assessed at baseline and 3 months after opioid titration in 231 opioid naïve CNCP patients. 30700073 2019
CUI: C0030193
Disease: Pain
Pain
0.060 Biomarker phenotype BEFREE At month 3, statistically significant improvements from baseline versus placebo were reported in PtGA, Pain, HAQ DI, all 8 SF-36 domains, FACIT-F, and MOS Sleep with tofacitinib 10 mg BID, and in PtGA, Pain, HAQ DI, 7 SF-36 domains, FACIT-F, and MOS Sleep with tofacitinib 5 mg BID. 27565000 2017
CUI: C0030193
Disease: Pain
Pain
0.060 Biomarker phenotype BEFREE Evaluation of pain intensity in people with rheumatoid arthritis using the MOS intensity scale. 29807861 2019
CUI: C0030193
Disease: Pain
Pain
0.060 GeneticVariation phenotype BEFREE The Brief Pain Inventory (BPI), Hospital Anxiety and Depression Scale (HADS), and sleep scale developed for the MOS study (MOS-SQ) were used to measure pain features and psychosocial adjustment. 27782366 2017
CUI: C0030193
Disease: Pain
Pain
0.060 GeneticVariation phenotype BEFREE The scores in all sleep dimensions of the MOS-sleep were higher in CPP (more disturbances) compared to pain free patients, and differences were observed among the three groups of PCP, with FM most severely affected. 28945136 2018
CUI: C0030193
Disease: Pain
Pain
0.060 Biomarker phenotype BEFREE This longitudinal mailed survey study examined Health Promoting Lifestyle Profile II (HPLP) scores and MOS SF 36 scores as predictors of PROMIS® Pain Interference, Pain Intensity, Fatigue, Sleep Disturbance, and Applied Cognition Abilities Scores among 260 adults with MS. 31045426 2019